SEDI Insider filing browser
Filter by Company
×
Filter by $CAD Amount
×
Filter by Filing Type
Filter by Insider
×
 
Date Issuer Insider Transaction Amount New Balance ⓘ
The balance of securities held by registered holder at the time of the transaction. Insiders may direct multiple registered holders and hold multiple security types.
Filed 2020-06-05 10:04
Tx date 2020-05-27 		$CORV
Correvio Pharma Corp. 		ADVANZ PHARMA Corp. Limited
3 - 10% Security Holder of Issuer
Holder: Mercury Pharma Group Limited (Indirect Ownership)
Common Shares
00 - Opening Balance-Initial SEDI Report 		66,194,317
Filed 2020-03-30 19:10
Tx date 2018-05-15 		$CORV
Correvio Pharma Corp. 		Willms, Arthur Henry
4 - Director of Issuer
Direct Ownership
Options
00 - Opening Balance-Initial SEDI Report 		79,000
Filed 2020-03-30 14:50
Tx date 2018-05-15 		$CORV
Correvio Pharma Corp. 		Willms, Arthur Henry
4 - Director of Issuer
Direct Ownership
Common Shares
00 - Opening Balance-Initial SEDI Report 		18,000
Filed 2020-03-29 15:34
Tx date 2020-03-26 		$CORV
Correvio Pharma Corp. 		Hunter, William L.
4 - Director of Issuer
Direct Ownership
Options
52 - Expiration of options 		$-1,345,500
-130,000 vol
$10.35 each 		1,120,000
Filed 2020-03-29 15:32
Tx date 2020-03-26 		$CORV
Correvio Pharma Corp. 		Sachot, Hugues
5 - Senior Officer of Issuer
Direct Ownership
Options
52 - Expiration of options 		$-338,445
-32,700 vol
$10.35 each 		0
Filed 2020-03-29 15:30
Tx date 2020-03-26 		$CORV
Correvio Pharma Corp. 		McMasters, David D.
5 - Senior Officer of Issuer
Direct Ownership
Options
52 - Expiration of options 		$-338,445
-32,700 vol
$10.35 each 		425,000
Filed 2020-03-29 15:27
Tx date 2020-03-26 		$CORV
Correvio Pharma Corp. 		Grant, Sheila
5 - Senior Officer of Issuer
Direct Ownership
Options
52 - Expiration of options 		$-338,445
-32,700 vol
$10.35 each 		425,000
Filed 2020-03-24 15:06
Tx date 2018-05-15 		$CORV
Correvio Pharma Corp. 		Grant, Sheila
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
00 - Opening Balance-Initial SEDI Report 		12,991
Filed 2020-03-16 15:53
Tx date 2018-03-15 		$CORV
Correvio Pharma Corp. 		Sachot, Hugues
5 - Senior Officer of Issuer
Direct Ownership
Options
00 - Opening Balance-Initial SEDI Report 		32,700
Filed 2020-03-16 15:50
Tx date 2019-03-14 		$CORV
Correvio Pharma Corp. 		Hunter, William L.
4 - Director of Issuer
Holder: Cathryn Hunter (Indirect Ownership)
Common Shares
00 - Opening Balance-Initial SEDI Report 		28,935
Filed 2020-03-16 15:49
Tx date 2019-03-14 		$CORV
Correvio Pharma Corp. 		Hunter, William L.
4 - Director of Issuer
Direct Ownership
Common Shares
00 - Opening Balance-Initial SEDI Report 		991,946
Filed 2020-03-16 15:48
Tx date 2018-05-15 		$CORV
Correvio Pharma Corp. 		Dean, David Cameron Peter
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
00 - Opening Balance-Initial SEDI Report 		14,500
Filed 2019-12-13 13:10
Tx date 2019-12-13 		$CORV
Correvio Pharma Corp. 		Meyer, Robert James
4 - Director of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market 		$-3,368
-8,420 vol
$0.40 each 		0
Filed 2019-08-15 16:24
Tx date 2019-08-13 		$CORV
Correvio Pharma Corp. 		O'Shea, William James
4 - Director of Issuer
Direct Ownership
Options
52 - Expiration of options 		$-164,386.02
-19,974 vol
$8.23 each 		99,000
Filed 2019-08-15 16:21
Tx date 2019-08-13 		$CORV
Correvio Pharma Corp. 		Grant, Sheila
5 - Senior Officer of Issuer
Direct Ownership
Options
52 - Expiration of options 		$-205,750
-25,000 vol
$8.23 each 		457,700
Filed 2019-08-15 16:11
Tx date 2019-08-13 		$CORV
Correvio Pharma Corp. 		Hunter, William L.
4 - Director of Issuer
Direct Ownership
Options
52 - Expiration of options 		$-823,000
-100,000 vol
$8.23 each 		1,250,000
Filed 2019-08-15 15:57
Tx date 2019-08-13 		$CORV
Correvio Pharma Corp. 		McMasters, David D.
5 - Senior Officer of Issuer
Direct Ownership
Options
52 - Expiration of options 		$-164,600
-20,000 vol
$8.23 each 		457,700
Filed 2019-06-27 18:57
Tx date 2019-06-25 		$CORV
Correvio Pharma Corp. 		O'Shea, William James
4 - Director of Issuer
Direct Ownership
Options
50 - Grant of options 		$57,750
+25,000 vol
$2.31 each 		118,974
Filed 2019-06-27 18:54
Tx date 2019-06-25 		$CORV
Correvio Pharma Corp. 		Meyer, Robert James
4 - Director of Issuer
Direct Ownership
Options
50 - Grant of options 		$46,200
+20,000 vol
$2.31 each 		75,100
Filed 2019-06-27 18:48
Tx date 2019-06-25 		$CORV
Correvio Pharma Corp. 		Glickman, Richard
4 - Director of Issuer
Direct Ownership
Options
50 - Grant of options 		$60,000
+20,000 vol
$3.00 each 		75,000
Filed 2019-06-27 18:44
Tx date 2019-06-25 		$CORV
Correvio Pharma Corp. 		De Cian, Vanda
4 - Director of Issuer
Direct Ownership
Options
50 - Grant of options 		$11,550
+5,000 vol
$2.31 each 		35,000
Filed 2019-06-27 18:40
Tx date 2019-06-25 		$CORV
Correvio Pharma Corp. 		Hunter, William L.
4 - Director of Issuer
Direct Ownership
Options
50 - Grant of options 		$60,000
+20,000 vol
$3.00 each 		1,350,000
Filed 2019-06-27 18:39
Tx date 2019-03-14 		$CORV
Correvio Pharma Corp. 		Hunter, William L.
4 - Director of Issuer
Direct Ownership
Options
00 - Opening Balance-Initial SEDI Report 		1,330,000
Filed 2019-06-27 18:16
Tx date 2019-06-25 		$CORV
Correvio Pharma Corp. 		Corrigan, Mark
4 - Director of Issuer
Direct Ownership
Options
50 - Grant of options 		$1,564,000
+400,000 vol
$3.91 each 		1,059,000
Filed 2019-06-20 16:54
Tx date 2019-06-18 		$CORV
Correvio Pharma Corp. 		Corrigan, Mark
4 - Director of Issuer
Direct Ownership
Options
38 - Redemption, retraction, cancellation, repurchase 		$-1,564,000
-400,000 vol
$3.91 each 		659,000
Filed 2019-03-20
Tx date 2018-05-25 		$CORV
Correvio Pharma Corp. 		McMasters, David D.
5 - Senior Officer of Issuer
Direct Ownership
Options
00 - Opening Balance-Initial SEDI Report 		377,700
Filed 2019-03-20
Tx date 2018-05-25 		$CORV
Correvio Pharma Corp. 		Renz, Justin
5 - Senior Officer of Issuer
Direct Ownership
Options
00 - Opening Balance-Initial SEDI Report 		425,000
Filed 2019-03-20
Tx date 2019-03-15 		$CORV
Correvio Pharma Corp. 		Grant, Sheila
5 - Senior Officer of Issuer
Direct Ownership
Options
50 - Grant of options 		$523,000
+100,000 vol
$5.23 each 		482,700
Filed 2019-03-20
Tx date 2019-03-15 		$CORV
Correvio Pharma Corp. 		Renz, Justin
5 - Senior Officer of Issuer
Direct Ownership
Options
50 - Grant of options 		$684,250
+175,000 vol
$3.91 each 		600,000
Filed 2019-03-20
Tx date 2018-05-15 		$CORV
Correvio Pharma Corp. 		Grant, Sheila
5 - Senior Officer of Issuer
Direct Ownership
Options
00 - Opening Balance-Initial SEDI Report 		382,700
Filed 2019-03-20
Tx date 2019-03-15 		$CORV
Correvio Pharma Corp. 		Corrigan, Mark
4 - Director of Issuer
Direct Ownership
Options
50 - Grant of options 		$1,564,000
+400,000 vol
$3.91 each 		1,059,000
Filed 2019-03-20
Tx date 2018-05-15 		$CORV
Correvio Pharma Corp. 		Dean, David Cameron Peter
5 - Senior Officer of Issuer
Direct Ownership
Options
00 - Opening Balance-Initial SEDI Report 		375,000
Filed 2019-03-20
Tx date 2019-03-15 		$CORV
Correvio Pharma Corp. 		Dean, David Cameron Peter
5 - Senior Officer of Issuer
Direct Ownership
Options
50 - Grant of options 		$523,000
+100,000 vol
$5.23 each 		475,000
Filed 2019-03-20
Tx date 2019-03-15 		$CORV
Correvio Pharma Corp. 		McMasters, David D.
5 - Senior Officer of Issuer
Direct Ownership
Options
50 - Grant of options 		$391,000
+100,000 vol
$3.91 each 		477,700
Filed 2019-03-20
Tx date 2019-03-15 		$CORV
Correvio Pharma Corp. 		Corrigan, Mark
4 - Director of Issuer
Direct Ownership
Options
50 - Grant of options 		$2,346,000
+600,000 vol
$3.91 each 		659,000
Filed 2019-03-19
Tx date 2019-03-15 		$CORV
Correvio Pharma Corp. 		De Cian, Vanda
4 - Director of Issuer
Direct Ownership
Options
50 - Grant of options 		$117,300
+30,000 vol
$3.91 each 		30,000
Filed 2019-03-19
Tx date 2019-03-12 		$CORV
Correvio Pharma Corp. 		De Cian, Vanda
4 - Director of Issuer
Direct Ownership
Options
00 - Opening Balance-Initial SEDI Report
Filed 2019-01-16
Tx date 2018-05-25 		$CORV
Correvio Pharma Corp. 		Renz, Justin
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
00 - Opening Balance-Initial SEDI Report 		30,000
Filed 2019-01-16
Tx date 2019-01-15 		$CORV
Correvio Pharma Corp. 		Renz, Justin
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market 		$44,000
+20,000 vol
$2.20 each 		50,000
Filed 2018-11-23
Tx date 2018-11-20 		$CORV
Correvio Pharma Corp. 		Glickman, Richard
4 - Director of Issuer
Direct Ownership
Options
52 - Expiration of options 		$-76,500
-15,000 vol
$5.10 each 		55,000
Filed 2018-08-21
Tx date 2018-08-16 		$CORV
Correvio Pharma Corp. 		McMasters, David D.
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market 		$-49,800
-10,000 vol
$4.98 each 		29,093
Filed 2018-06-28
Tx date 2018-06-27 		$CORV
Correvio Pharma Corp. 		McMasters, David D.
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market 		$-21,403.46
-5,603 vol
$3.82 each 		39,093
Filed 2018-06-26
Tx date 2018-05-25 		$CORV
Correvio Pharma Corp. 		McMasters, David D.
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
00 - Opening Balance-Initial SEDI Report 		48,696
Filed 2018-06-26
Tx date 2018-06-21 		$CORV
Correvio Pharma Corp. 		McMasters, David D.
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market 		$-14,880
-4,000 vol
$3.72 each 		44,696
Filed 2018-06-20
Tx date 2018-06-19 		$CORV
Correvio Pharma Corp. 		Meyer, Robert James
4 - Director of Issuer
Direct Ownership
Options
50 - Grant of options 		$73,600
+20,000 vol
$3.68 each 		55,100
Filed 2018-06-20
Tx date 2018-05-25 		$CORV
Correvio Pharma Corp. 		O'Shea, William James
4 - Director of Issuer
Direct Ownership
Common Shares
00 - Opening Balance-Initial SEDI Report 		25,000
Filed 2018-06-20
Tx date 2018-05-25 		$CORV
Correvio Pharma Corp. 		O'Shea, William James
4 - Director of Issuer
Direct Ownership
Options
00 - Opening Balance-Initial SEDI Report 		68,974
Filed 2018-06-20
Tx date 2018-06-19 		$CORV
Correvio Pharma Corp. 		O'Shea, William James
4 - Director of Issuer
Direct Ownership
Options
50 - Grant of options 		$92,000
+25,000 vol
$3.68 each 		93,974
Filed 2018-06-20
Tx date 2018-05-25 		$CORV
Correvio Pharma Corp. 		Corrigan, Mark
3 - 10% Security Holder of Issuer
Direct Ownership
Options
00 - Opening Balance-Initial SEDI Report 		39,000
Filed 2018-06-20
Tx date 2018-05-25 		$CORV
Correvio Pharma Corp. 		Glickman, Richard
4 - Director of Issuer
Direct Ownership
Options
00 - Opening Balance-Initial SEDI Report 		50,000
Filed 2018-06-20
Tx date 2018-06-19 		$CORV
Correvio Pharma Corp. 		Corrigan, Mark
3 - 10% Security Holder of Issuer
Direct Ownership
Options
50 - Grant of options 		$73,600
+20,000 vol
$3.68 each 		59,000
Filed 2018-06-20
Tx date 2018-05-25 		$CORV
Correvio Pharma Corp. 		Corrigan, Mark
3 - 10% Security Holder of Issuer
Direct Ownership
Common Shares
00 - Opening Balance-Initial SEDI Report 		10,000
Filed 2018-06-20
Tx date 2018-05-25 		$CORV
Correvio Pharma Corp. 		Glickman, Richard
4 - Director of Issuer
Direct Ownership
Common Shares
00 - Opening Balance-Initial SEDI Report 		14,444
Filed 2018-06-20
Tx date 2018-06-19 		$CORV
Correvio Pharma Corp. 		Glickman, Richard
4 - Director of Issuer
Direct Ownership
Options
50 - Grant of options 		$97,000
+20,000 vol
$4.85 each 		70,000
Filed 2018-06-20
Tx date 2018-05-25 		$CORV
Correvio Pharma Corp. 		Meyer, Robert James
4 - Director of Issuer
Direct Ownership
Common Shares
00 - Opening Balance-Initial SEDI Report 		8,420
Filed 2018-06-20
Tx date 2018-05-25 		$CORV
Correvio Pharma Corp. 		Meyer, Robert James
4 - Director of Issuer
Direct Ownership
Options
00 - Opening Balance-Initial SEDI Report 		35,100